No rigorous clinical trial has shown that cannabis reliably treats vertigo, and the existing evidence leans in the opposite direction: cannabis frequently causes dizziness and balance problems on its own. The idea is not entirely baseless, because cannabinoid receptors do exist in the brain regions that process balance, and cannabis is a proven antiemetic that could ease the nausea vertigo brings. But the gap between biological plausibility and proven treatment is enormous, and for vertigo specifically, cannabis sits squarely in that gap.
Why People Suspect Cannabis Might Help
The reasoning usually goes like this: cannabis calms the nervous system, reduces nausea, and eases anxiety, and vertigo involves all three of those things. There is a kernel of science behind this intuition. The body’s endocannabinoid system, which cannabis compounds interact with, does have a presence in the vestibular system, the network of brain structures and inner-ear organs that controls your sense of balance and spatial orientation.
CB1 receptors, the main targets of THC in the brain, were originally thought to be sparse in the vestibular nucleus complex, the brainstem hub that processes balance signals. More recent work using detailed tissue staining found that CB1 receptors may actually be present in numbers comparable to what is seen in parts of the cerebellum, a brain region heavily involved in motor coordination and balance.1Audiology and Neurotology. The Endocannabinoid System: A New Player in the Neurochemical Control of Vestibular Function? CB2 receptors, the other major cannabinoid receptor type, have also been confirmed in the vestibular and cochlear nuclei of the brainstem.2PubMed. Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei The endocannabinoid system’s role in otolaryngology, particularly regarding the vestibular system and inflammatory pain, has been acknowledged in clinical reviews.3Otolaryngologic Clinics of North America. The endocannabinoid system and otolaryngology
So the receptors are there. That means THC and other cannabinoids can, in theory, modulate how your brain processes balance information. But “can modulate” is not the same as “can fix.” Receptors are switches, and flipping them can make things better or worse depending on the context. In the case of vertigo, the evidence so far suggests cannabis tends to push things in the wrong direction.
Cannabis Frequently Causes Dizziness Itself
One of the most common side effects of cannabis, especially at higher doses, is dizziness. This is not a rare or disputed finding. It happens through a well-understood cardiovascular mechanism: THC dilates blood vessels and reduces vascular resistance, which can cause a sudden drop in blood pressure when you stand up.4PubMed. Cardiovascular consequences of marijuana use This is orthostatic hypotension, and it produces the exact sensation that many vertigo sufferers are trying to escape: a spinning, unstable feeling when changing positions.
The numbers from controlled research are striking. In one study measuring brain blood flow during posture changes, both pure THC and smoked marijuana caused postural dizziness, with roughly 28% of participants reporting severe symptoms. The people who got hit hardest showed the most dramatic drops in cerebral blood velocity and blood pressure upon standing.5PubMed. Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics Separate reviews of cannabis and cardiovascular health have reinforced this pattern, noting that higher doses of cannabis can cause postural hypotension associated with dizziness or fainting.6PubMed Central. Role of cannabis in cardiovascular disorders
If you already have a condition that causes vertigo, such as benign paroxysmal positional vertigo (BPPV), Ménière’s disease, or vestibular neuritis, adding a substance that independently causes postural dizziness is a gamble with poor odds. You are layering a drug-induced balance disruption on top of an existing one.
What Cannabis Does to Balance and Eye Tracking
Vertigo is not just about feeling dizzy. It involves disrupted coordination between your eyes, your inner ear, and your body’s sense of where it is in space. Cannabis affects all three of these systems, and not in ways that help.
A systematic review of how cannabis affects eye movements found mixed but concerning results for smooth pursuit, the ability to track a moving object with your eyes. Out of four experimental studies examining THC’s effect on smooth pursuit, two found significant impairments: one showed a decrease in the percentage of time the eyes stayed in smooth pursuit mode, and another found reduced pursuit speeds at a dose of about 25 mg THC.7PubMed Central. A systematic review of oculomotor deficits associated with acute and chronic cannabis use The other two studies, using lower doses, found no significant differences from placebo. The takeaway is dose-dependent: at higher doses, THC appears to degrade the eye-tracking reflexes that your vestibular system relies on to keep the visual world stable.
Postural stability, your ability to stand upright without swaying, also takes a hit. A study comparing cannabis users to non-users found that the cannabis group had significantly increased path length when standing still, meaning their bodies swayed more. They also showed increased trembling in both front-to-back and side-to-side directions.8PubMed Central. Disturbances of postural sway components in cannabis users For someone with vertigo, who already struggles with balance, adding a substance that measurably worsens postural control is counterproductive.
The Nausea Argument Has Some Merit, With Limits
The strongest case for cannabis in the context of vertigo is not about vertigo itself but about the nausea and vomiting that often accompany it. Vertigo attacks, particularly severe ones from Ménière’s disease or vestibular migraines, can trigger intense nausea. Cannabis has genuine antiemetic properties: THC reduces vomiting through CB1 receptors in the brainstem’s vomiting center (the dorsal vagal complex), and there is reasonable evidence for this effect in chemotherapy-induced nausea specifically.9PubMed Central. Potential effects of cannabinoids on audiovestibular function: A narrative review
However, the leap from “helps with chemo nausea” to “helps with vertigo nausea” is not straightforward. Chemotherapy-induced nausea originates from chemical irritation of the gut and brainstem. Vestibular nausea originates from conflicting signals between the inner ear and the visual system. These are different pathways, and a drug that works well for one type does not automatically work for the other. No controlled trial has tested whether cannabis effectively treats nausea specifically caused by vestibular episodes. The plausibility is there, but the proof is not.
There is also a practical problem: if cannabis reduces your nausea during a vertigo attack but simultaneously makes you dizzier through its cardiovascular and balance-impairing effects, you may have traded one symptom for a worsening of the underlying problem. Existing antiemetics like ondansetron or promethazine target nausea without destabilizing your balance, which makes them a more targeted choice for vertigo-associated nausea.
What Happens in the Cerebellum Over Time
The cerebellum, tucked beneath the back of the brain, plays a central role in balance, coordination, and motor learning. It is also one of the brain regions most consistently affected by chronic cannabis use, which matters for anyone considering cannabis as an ongoing vertigo treatment rather than a one-off experiment.
A systematic review of cerebellar changes in cannabis users found several recurring patterns: alterations in cerebellar resting-state activity after both acute and chronic use, and deficits in memory, decision-making, and associative learning that involve cerebellar circuits. Younger age of first use and heavier exposure were linked to more pronounced changes.10PubMed. Cerebellar alterations in cannabis users: A systematic review A separate study looking at sex-specific effects found that cannabis users had smaller cerebellar volume compared to controls, and that this reduction was driven primarily by female users.11PubMed Central. Cannabis Affects Cerebellar Volume and Sleep Differently in Men and Women
The cerebellum is not just involved in keeping you balanced while standing. It also drives vestibular compensation, the process by which your brain relearns how to process balance signals after an inner-ear injury. People who have had vestibular neuritis or a labyrinthectomy depend heavily on cerebellar plasticity to recover. Any substance that chronically alters cerebellar structure and function could, in theory, slow that recovery process. This concern is still speculative; no study has directly tested whether cannabis users recover from vestibular injuries more slowly. But the biological reasoning is not encouraging.
Vestibular Compensation and the Receptor Puzzle
After a sudden vestibular injury, such as the loss of function in one inner ear, the brain goes through a gradual process of recalibrating itself. This vestibular compensation is why most people who suffer from vestibular neuritis eventually feel better even without medical intervention. The brain learns to rely more on the healthy ear and on visual and proprioceptive cues.
Given that CB1 receptors are present in the vestibular nuclei, researchers have explored whether the endocannabinoid system plays a role in this compensation process. In an animal study that measured CB1 receptor expression in the vestibular nucleus complex after one side’s vestibular nerve was cut, CB1 receptor levels did not change significantly during the compensation period.12PubMed. Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation This is a single animal study and should not be over-interpreted, but it suggests that the endocannabinoid system may not be a major driver of natural vestibular recovery. If your body does not ramp up cannabinoid signaling to heal itself after a vestibular injury, flooding the system with external cannabinoids may not be doing what you hope.
An interesting side note from the broader research literature: at least one clinical trial has explored preparations containing antibodies against the CB1 receptor, essentially the opposite of activating it with THC, for vertigo tolerance. In healthy subjects exposed to a vertigo-inducing model, the CB1 receptor antagonist preparation increased tolerance to acceleration without changing nystagmus duration or recovery time.9PubMed Central. Potential effects of cannabinoids on audiovestibular function: A narrative review This is preliminary and from a narrow study design, but it is worth noting that blocking the CB1 receptor improved vertigo tolerance, which is the opposite of what cannabis does.
The Clinical Trial Gap
The most important thing to understand about cannabis and vertigo is what we do not have: a single randomized, controlled clinical trial testing cannabis as a treatment for any specific vertigo condition. Not for BPPV, the most common type. Not for Ménière’s disease, the most disabling. Not for vestibular migraine, the most undertreated. The evidence base consists of receptor studies in animals, observational data on cannabis side effects, and anecdotal patient reports.
This gap is not unique to vertigo. A critical analysis of the broader vestibular pharmacology literature has concluded that there is a significant lack of information defining the real utility of many drugs used in clinical vestibular practice, and that better basic science and well-controlled clinical trials are needed for new treatment strategies.13Journal of Vestibular Research. Neuropharmacological basis of vestibular system disorder treatment Cannabis falls squarely into this category. It is biologically plausible that cannabinoids could influence vestibular function in some way. But “influence” could mean improvement or worsening, and nobody has done the rigorous work to determine which.
The anecdotal reports that circulate online, where people describe cannabis helping their vertigo, are real experiences but unreliable guides. Vertigo conditions like BPPV are episodic and often self-resolving. Ménière’s attacks come and go unpredictably. If someone smokes cannabis during a vertigo episode that was already winding down, it is easy to credit the cannabis for the improvement. Without a control group, there is no way to separate the drug’s effect from the natural course of the disease. People who try cannabis during an episode that gets worse, meanwhile, tend not to write glowing testimonials about it.
How Different Vertigo Conditions Respond to Medication Generally
Part of the confusion around cannabis and vertigo stems from treating “vertigo” as a single condition. It is a symptom, not a diagnosis, and the causes vary enormously. The drug that helps one type of vertigo may do nothing for another.
- BPPV: Caused by loose calcium crystals in the inner ear. No medication fixes it; the standard treatment is a repositioning maneuver (the Epley maneuver) that physically moves the crystals. Cannabis cannot move crystals.
- Vestibular neuritis: Caused by inflammation of the vestibular nerve, usually from a viral infection. Acute treatment involves vestibular suppressants and steroids. Recovery depends on vestibular compensation, a brain-plasticity process that cannabis’s cerebellar effects could theoretically hinder.
- Ménière’s disease: Involves abnormal fluid pressure in the inner ear. Treatment focuses on dietary salt restriction, diuretics, and sometimes steroid injections. The nausea component is severe, which is where the antiemetic argument for cannabis is strongest, but the dizziness-inducing side effects remain a concern.
- Vestibular migraine: A neurological condition where the migraine process itself triggers vertigo. Treated with migraine preventives. Some migraine sufferers report that cannabis helps their headaches, but the vestibular component adds the balance-disruption concern that does not apply to ordinary migraines.
For BPPV, the most common cause of vertigo, no drug of any kind is the answer. For the other conditions, the available evidence points toward cannabis being more likely to complicate recovery than to aid it, though nobody has definitively proven this either way.
The Dose and Delivery Problem
Cannabis is not a single substance. The plant contains over a hundred cannabinoids, and the two most discussed, THC and CBD, have very different pharmacological profiles. THC is the psychoactive component responsible for most of the cardiovascular and balance-impairing effects described above. CBD is non-intoxicating and has anti-inflammatory and anxiolytic properties in some contexts, with far less evidence of causing dizziness.
Most of the concerning findings about cannabis and balance involve THC specifically or whole-plant cannabis with significant THC content. Nobody has studied whether a CBD-dominant product, with minimal THC, would carry the same risks for vertigo patients. It is plausible that low-THC, high-CBD formulations would avoid the blood-pressure drops and oculomotor impairments that THC causes, while potentially offering anti-inflammatory or anti-anxiety benefits that could indirectly help with some vertigo conditions. But “plausible” and “proven” are very different things, and no clinical data supports this approach yet.
Route of administration matters too. Smoking or vaping delivers a rapid spike of THC to the brain, which is more likely to trigger acute hypotension and dizziness. Edibles produce a slower, more sustained absorption, which might reduce the postural blood-pressure drop but also makes dosing harder to control and extends the duration of any negative effects. Sublingual tinctures fall somewhere in between. For someone whose main vertigo complaint is positional dizziness when standing, the rapid cardiovascular hit from inhaled THC is the worst possible delivery mechanism.
When Cannabis Might Be Worth Discussing With a Doctor
There is one narrow scenario where cannabis enters the conversation for vertigo patients in a way that is not purely speculative: when severe nausea and vomiting dominate the clinical picture and standard antiemetics have failed. In Ménière’s disease, vestibular crises can involve hours of violent vomiting that leave patients dehydrated and debilitated. If conventional antiemetics do not control the vomiting, a physician might consider cannabinoid-based options like dronabinol (synthetic THC, FDA-approved for chemotherapy nausea) as a rescue measure. This is off-label use, and the physician would need to weigh the potential antiemetic benefit against the risk of worsening the dizziness itself.
Outside of that specific scenario, there is no evidence-based reason to use cannabis for vertigo. The biological plausibility that cannabinoid receptors in the vestibular system could be therapeutically targeted is real, but the current evidence suggests that activating those receptors with THC may be the wrong direction entirely, given the preliminary finding that blocking CB1 receptors improved vertigo tolerance in one model. Future drug development in this area may well involve the endocannabinoid system, but the resulting drugs would likely look nothing like the cannabis products available today. They would be precision-targeted compounds, not whole-plant preparations with a side-effect profile that includes the very symptom you are trying to treat.